Rivaroxaban: A Review of Its Use in the Treatment of Deep Vein Thrombosis or Pulmonary Embolism and the Prevention of Recurrent Venous Thromboembolism
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rivaroxaban: A Review of Its Use in the Treatment of Deep Vein Thrombosis or Pulmonary Embolism and the Prevention of Recurrent Venous Thromboembolism
Authors
Keywords
Enoxaparin, Rivaroxaban, Evidence Review Group, Rivaroxaban Plasma Concentration, Routine Coagulation Monitoring
Journal
DRUGS
Volume 74, Issue 2, Pages 243-262
Publisher
Springer Nature
Online
2014-01-15
DOI
10.1007/s40265-013-0174-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incidence of neuraxial haematoma after total hip or knee surgery: RECORD programme (rivaroxaban vs. enoxaparin)
- (2013) N. ROSENCHER et al. ACTA ANAESTHESIOLOGICA SCANDINAVICA
- Meta-Analysis of Rivaroxaban and Bleeding Risk
- (2013) Guila Wasserlauf et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor
- (2013) Dagmar Kubitza et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects
- (2013) Wolfgang Mueck et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Rivaroxaban: A Review of its Use in the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation
- (2013) Natalie J. Carter et al. DRUGS
- Efficacy and Safety of New Oral Anticoagulants for Extended Treatment of Venous Thromboembolism: Systematic Review and Meta-Analyses of Randomized Controlled Trials
- (2013) Partha Sardar et al. DRUGS
- The Influence of Age and Gender on the Pharmacokinetics and Pharmacodynamics of Rivaroxaban-An Oral, Direct Factor Xa Inhibitor
- (2013) Dagmar Kubitza et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban
- (2012) Sean T. Duggan American Journal of Cardiovascular Drugs
- Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: Guidance from the British Committee for Standards in Haematology
- (2012) Trevor Baglin et al. BRITISH JOURNAL OF HAEMATOLOGY
- Management of Bleeding in Patients Receiving Conventional or New Anticoagulants
- (2012) Marco P. Donadini et al. DRUGS
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials
- (2012) B. D. Fox et al. BMJ-British Medical Journal
- Evaluation of Prothrombin Complex Concentrate and Recombinant Activated Factor VII to Reverse Rivaroxaban in a Rabbit Model
- (2011) Anne Godier et al. ANESTHESIOLOGY
- Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate
- (2011) Elise S. Eerenberg et al. CIRCULATION
- Rivaroxaban
- (2011) Wolfgang Mueck et al. CLINICAL PHARMACOKINETICS
- Venous and arterial thrombosis – pathogenesis and the rationale for anticoagulation
- (2011) Charles Esmon et al. THROMBOSIS AND HAEMOSTASIS
- Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls
- (2011) Genevieve Contant et al. THROMBOSIS AND HAEMOSTASIS
- Venous Thromboembolism
- (2010) Michele G. Beckman et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor
- (2010) Dagmar Kubitza et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Topical Issues in Venous Thromboembolism
- (2010) José Ignacio Abad Rico et al. DRUGS
- Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology
- (2010) Wiebke Gogarten et al. EUROPEAN JOURNAL OF ANAESTHESIOLOGY
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Assessment of laboratory assays to measure rivaroxaban – an oral, direct factor Xa inhibitor
- (2010) Jean-Luc Martinoli et al. THROMBOSIS AND HAEMOSTASIS
- Metabolism and Excretion of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor, in Rats, Dogs, and Humans
- (2009) C. Weinz et al. DRUG METABOLISM AND DISPOSITION
- Randomized, Double-Blind, Crossover Study to Investigate the Effect of Rivaroxaban on QT-Interval Prolongation
- (2009) Dagmar Kubitza et al. DRUG SAFETY
- Rivaroxaban
- (2009) Sean T. Duggan et al. DRUGS
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
- (2009) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study
- (2008) H. R. Buller et al. BLOOD
- Rivaroxaban - an oral, direct Factor Xa inhibitor - has potential for the management of patients with heparin-induced thrombocytopenia
- (2008) Jeanine M. Walenga et al. BRITISH JOURNAL OF HAEMATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started